Podcast: Non-binding Guidance: SEC Disclosure Issues for Life Sciences Companies
The recent 2025 fee setting by the USPTO includes not only fee increases, but the introduction of new fees. One of these new fees is the so-called Information Disclosure Statement (IDS) size fees, which adds a range of fees...more